NASDAQ:NTLA

Intellia Therapeutics, Inc.

Read NTLA's Filings Free

Company facts

Most recent report
10-Q, filed Aug 6, 2026
Incorporated
Delaware
Filings on record
711 filings
On EDGAR
CIK 1652130
Fiscal year ends
December
Filer status
Large accelerated filer

Financials 8 of 44

News 8 of 135

Prospectuses and Registrations 8 of 41

Proxies 8 of 20

Ownership 8 of 430

Other 8 of 41

Everything here comes from Intellia Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.